Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
Shiyu Yin, Ming Huang, Dengju Li, et al.
Journal of Thrombosis and Thrombolysis (2020) Vol. 51, Iss. 4, pp. 1107-1110
Open Access | Times Cited: 438

Showing 1-25 of 438 citing articles:

Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
Ishan Paranjpe, Valentı́n Fuster, Anuradha Lala, et al.
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 1, pp. 122-124
Open Access | Times Cited: 944
Biomarkers associated with COVID-19 disease progression
Giovanni Ponti, Monia Maccaferri, Cristel Ruini, et al.
Critical Reviews in Clinical Laboratory Sciences (2020) Vol. 57, Iss. 6, pp. 389-399
Open Access | Times Cited: 854
Coagulopathy of Coronavirus Disease 2019
Toshiaki Iba, Jerrold H. Levy, Marcel Levi, et al.
Critical Care Medicine (2020) Vol. 48, Iss. 9, pp. 1358-1364
Open Access | Times Cited: 521
The Impact of COVID-19 Disease on Platelets and Coagulation
Geoffrey D. Wool, Jonathan Miller
Pathobiology (2020) Vol. 88, Iss. 1, pp. 15-27
Open Access | Times Cited: 510
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection
Franklin L. Wright, Thomas O. Vogler, Ernest E. Moore, et al.
Journal of the American College of Surgeons (2020) Vol. 231, Iss. 2, pp. 193-203e1
Open Access | Times Cited: 409
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
Sean X. Gu, Tarun Tyagi, Kanika Jain, et al.
Nature Reviews Cardiology (2020) Vol. 18, Iss. 3, pp. 194-209
Open Access | Times Cited: 371
COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
Donato Gemmati, Barbara Bramanti, Maria Luisa Serino, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3474-3474
Open Access | Times Cited: 369
D-dimer level in COVID-19 infection: a systematic review
Mehrdad Rostami, Hassan Mansouritorghabeh
Expert Review of Hematology (2020) Vol. 13, Iss. 11, pp. 1265-1275
Closed Access | Times Cited: 360
Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms
Gregorio Tersalvi, Marco Vicenzi, Davide Calabretta, et al.
Journal of Cardiac Failure (2020) Vol. 26, Iss. 6, pp. 470-475
Open Access | Times Cited: 332
COVID‐19 and the clinical hematology laboratory
John L. Frater, Gina Zini, Giuseppe d’Onofrio, et al.
International Journal of Laboratory Hematology (2020) Vol. 42, Iss. S1, pp. 11-18
Open Access | Times Cited: 300
Current status of potential therapeutic candidates for the COVID-19 crisis
Jiancheng Zhang, Bing Xie, Kenji Hashimoto
Brain Behavior and Immunity (2020) Vol. 87, pp. 59-73
Open Access | Times Cited: 286
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
Mathieu Artifoni, Gwenvael Danic, Giovanni Gautier, et al.
Journal of Thrombosis and Thrombolysis (2020) Vol. 50, Iss. 1, pp. 211-216
Open Access | Times Cited: 282
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Mahesh V. Madhavan, Behnood Bikdeli, Aakriti Gupta, et al.
Thrombosis and Haemostasis (2020) Vol. 120, Iss. 07, pp. 1004-1024
Open Access | Times Cited: 243
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications
Joan T. Merrill, Doruk Erkan, Jerald Winakur, et al.
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 10, pp. 581-589
Open Access | Times Cited: 231
Coagulation and anticoagulation in COVID-19
Tarik Hadid, Zyad Kafri, Ayad Al-Katib
Blood Reviews (2020) Vol. 47, pp. 100761-100761
Open Access | Times Cited: 212
Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID‐19
Sarah C J Jorgensen, Christopher L.Y. Tse, Lisa Burry, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2020) Vol. 40, Iss. 8, pp. 843-856
Open Access | Times Cited: 195
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
Vittorio Pavoni, Lara Gianesello, Maddalena Pazzi, et al.
Journal of Thrombosis and Thrombolysis (2020) Vol. 50, Iss. 2, pp. 281-286
Open Access | Times Cited: 191
Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology
Simon J. Cleary, Simon C. Pitchford, Richard T. Amison, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 21, pp. 4851-4865
Open Access | Times Cited: 181
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents
Anton De Spiegeleer, Antoon Bronselaer, James Teo, et al.
Journal of the American Medical Directors Association (2020) Vol. 21, Iss. 7, pp. 909-914.e2
Open Access | Times Cited: 168
Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020
Karima Benameur, Ankita Agarwal, Sara C. Auld, et al.
Emerging infectious diseases (2020) Vol. 26, Iss. 9, pp. 2016-2021
Open Access | Times Cited: 167
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis
Bilian Yu, Xin Li, Jin Chen, et al.
Journal of Thrombosis and Thrombolysis (2020) Vol. 50, Iss. 3, pp. 548-557
Open Access | Times Cited: 162
Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19
Marcelo Macedo Rogero, Matheus de Castro Leão, Tamires Miranda Santana, et al.
Free Radical Biology and Medicine (2020) Vol. 156, pp. 190-199
Open Access | Times Cited: 162
Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management
Luis Ortega‐Paz, Davide Capodanno, Gilles Montalescot, et al.
Journal of the American Heart Association (2020) Vol. 10, Iss. 3
Open Access | Times Cited: 162
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients
Yan Zhang, Wei Cao, Wei Jiang, et al.
Journal of Thrombosis and Thrombolysis (2020) Vol. 50, Iss. 3, pp. 580-586
Open Access | Times Cited: 160
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
Eugenia Quirós-Roldán, Giorgio Biasiotto, Paola Magro, et al.
Pharmacological Research (2020) Vol. 158, pp. 104904-104904
Open Access | Times Cited: 156
Page 1 - Next Page

Scroll to top